Exploring proton therapy's effectiveness on the most common form of lung cancer
Proton therapy can deliver a higher radiation dose to lung tumors and a lower dose to healthy tissue compared to standard radiation therapy. However, the effectiveness of proton therapy has not yet been documented in clinical trials for patients with non–small cell lung cancer (NSCLC), the most common type of lung cancer. Two ongoing trials of proton therapy aim to demonstrate its effectiveness and may change the standard of care for...
Implantable devices track cardiac events in cancer patients
Cancer survivors are more likely to die from heart disease than cancer; therefore, patients must be closely monitored for heart problems during...
A simple answer for patients with Lynch syndrome
People with Lynch syndrome face a high risk of colorectal cancer. But researchers think that reducing this risk may be as easy as taking a...